← Leaderboards
Michael A Erb
Scripps Research Institute, The
$3,569,924
Attributed
$3,569,924
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $580.3K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,569,924 · 2
By mechanism
DP5$2,418,750 · 1
R01$1,151,174 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Andrew I Su$25,032,358
- Peter Edwin Wright$37,349,507
- Xiaohua Wu$21,837,222
- Daniel Nomura$13,467,439
- Eros Lazzerini Denchi$2,778,532
Others in their field
Other Emerging Leaders on “Small Molecule”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Susan Abushakra · Alzheon, Inc.$50,765,244
- John Damon Chodera · Sloan-Kettering Inst Can Research$32,426,535
- Xinhua Li · Nano Terra, Inc.$29,432,783
- Leonard Freedman · Leidos Biomedical Research, Inc.$14,890,784
- Alan Johnson · Hawaii Biotech, Inc.$14,045,226
Research focus
Small MoleculeBindingIn VivoProteinsMediatingCell SurvivalGeneticIn VitroLysineOutputStructureChromatin StructureChromatinMalignant NeoplasmsExperimental StudyGenesGenetic TranscriptionCancer CellBiologyBiological ModelsBiologicalCell ModelBiochemicalAffinity
Grant awards (7)
Cancer-specific dependencies within the NuRD chromatin remodeler complex: new targets and chemical tools$580,318
R01 · FY2025 · CA · contact PI
Cancer-specific dependencies within the NuRD chromatin remodeler complex: new targets and chemical tools$570,856
R01 · FY2024 · CA · contact PI
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia$483,750
DP5 · FY2022 · OD · contact PI
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia$483,750
DP5 · FY2021 · OD · contact PI
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia$483,750
DP5 · FY2020 · OD · contact PI
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia$483,750
DP5 · FY2019 · OD · contact PI
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia$483,750
DP5 · FY2018 · OD · contact PI